The world of drug discovery and chemical probes is still protein-centric and developing highly selective small molecules targeting RNA is often considered to be an insurmountable challenge. This view is now changing given the recent progress and scientific breakthroughs in understanding the fundamental biology and function of RNA, opening the door to RNA targeted small molecule drug discovery.
Why You Should Attend the RNA- Targeted Drug Discovery Summit
Explore how to optimize medicinal chemistry insights & RNA biology to enhance robust translation with The Scripps Research Institute, Anima Biotech & Arrakis Therapeutics
Successfully target RNA via interfering with RNA-protein interactions/ Epitranscriptomics with insights from Storm Therapeutics, Accent Therapeutics & Saverna Therapeutics
Expand your knowledge of RNA structure, function & role in disease with insights from Yale University, H3 Biomedicine & Whitehead Institute for Biomedical Research
Advance identification & validation of viable RNA target sites for therapeutic intervention with insights from PTC Therapeutics & Duke University
Overcome binding, selectivity & drug-like challenges of small molecules targeting RNA with insights from Roche, University of California San Diego & Novartis